The BIO CEO & Investor Conference, Feb. 10th. I would think that's enough time for the DMC to have detected a lapse of this nature. And then again when they okay'ed the trial for safety. Anything's possible, of course, but just putting out some thoughts.
Also, I think we are reaching closer to the point where DCVax-Direct will begin to come in more prominently in the NWBO narrative. So far it's been mostly obsessing over the DMC delay. That's also drowned out the German approvals. But only for now.
Market Data 
Markets 
AI
